Tanke Biosciences Corporation
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick servi… Read more
Tanke Biosciences Corporation (TNBI) - Total Assets
Latest total assets as of June 2025: $101.65K USD
Based on the latest financial reports, Tanke Biosciences Corporation (TNBI) holds total assets worth $101.65K USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tanke Biosciences Corporation - Total Assets Trend (2008–2024)
This chart illustrates how Tanke Biosciences Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tanke Biosciences Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Tanke Biosciences Corporation's total assets of $101.65K consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $24.00K | 36.6% |
Asset Composition Trend (2008–2024)
This chart illustrates how Tanke Biosciences Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tanke Biosciences Corporation's current assets represent 0.0% of total assets in 2024, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, the same as 0.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 36.6% of total assets.
Tanke Biosciences Corporation Competitors by Total Assets
Key competitors of Tanke Biosciences Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bexil Cp
PINK:BXLC
|
USA | $29.44 Million |
|
Norte Grande
SN:NORTEGRAN
|
Chile | CL$2.91 Billion |
|
BlackRock Capital Allocation Trust
NYSE:BCAT
|
USA | $1.87 Billion |
|
Big Tech 50 R&D-Limited Partnership
TA:BIGT
|
Israel | ILA14.08 Million |
|
Zhuhai Huajin Capital Co Ltd
SHE:000532
|
China | CN¥2.38 Billion |
|
Shaanxi International Trust Co Ltd
SHE:000563
|
China | CN¥29.45 Billion |
|
Sichuan Shuangma Cement Co Ltd
SHE:000935
|
China | CN¥9.30 Billion |
|
Sk Securities
KO:001510
|
Korea | ₩7.28 Trillion |
Tanke Biosciences Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Tanke Biosciences Corporation generates 0.99x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tanke Biosciences Corporation is currently not profitable relative to its asset base.
Tanke Biosciences Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.10 | 0.00 | 2.08 |
| Quick Ratio | 0.10 | 0.00 | 1.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-353.42K | $ -201.01K | $ 9.55 Million |
Tanke Biosciences Corporation - Advanced Valuation Insights
This section examines the relationship between Tanke Biosciences Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.02 |
| Latest Market Cap to Assets Ratio | 6.53 |
| Asset Growth Rate (YoY) | -5.3% |
| Total Assets | $65.52K |
| Market Capitalization | $428.17K USD |
Valuation Analysis
Premium Asset Valuation: The market values Tanke Biosciences Corporation's assets at a significant premium ( 6.53x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Tanke Biosciences Corporation's assets decreased by 5.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tanke Biosciences Corporation (2008–2024)
The table below shows the annual total assets of Tanke Biosciences Corporation from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $65.52K | -5.25% |
| 2023-12-31 | $69.16K | +845.01% |
| 2022-12-31 | $7.32K | -82.36% |
| 2021-12-31 | $41.49K | -99.86% |
| 2012-12-31 | $28.85 Million | +15.92% |
| 2011-12-31 | $24.89 Million | +87.59% |
| 2010-12-31 | $13.27 Million | +38.84% |
| 2009-12-31 | $9.56 Million | +1273932.27% |
| 2008-12-31 | $750.00 | -- |